Literature DB >> 7504540

Pertussis immunisation and serious acute neurological illnesses in children.

D Miller1, N Madge, J Diamond, J Wadsworth, E Ross.   

Abstract

OBJECTIVE: To determine long term outcome in children who had a severe acute neurological illness in early childhood associated with pertussis immunisation.
DESIGN: Follow up study of cases and matched controls.
SETTING: Assessment of children at home and at school throughout Britain.
SUBJECTS: Children recruited into the national childhood encephalopathy study in 1976-9 were followed up, with one of their two original matched controls, in 1986-9. MAIN OUTCOME MEASURES: Performance in educational attainment tests; behaviour problems reported by teachers and parents; continuing convulsions; evidence of other neurological or physical dysfunction.
RESULTS: Over 80% of cases and controls were traced. Case children were significantly more likely than controls to have died or to have some form of educational, behavioural, neurological, or physical dysfunction a decade after their illness. The prevalence of one or more of these adverse outcomes in case children who had been immunised with diphtheria, tetanus, and pertussis vaccine within seven days before onset of their original illness was similar to that in case children who had not been immunised recently. The relative risk for recent diphtheria, tetanus, and pertussis immunisation in children who had died or had any dysfunction in comparison with controls was 5.5 (95% confidence interval 1.6 to 23.7). However, the number of cases associated with vaccine (12) was extremely small and statistically vulnerable, and other possible agents or predisposing factors could not be excluded.
CONCLUSIONS: Diphtheria, tetanus, and pertussis vaccine may on rare occasions be associated with the development of severe acute neurological illnesses that can have serious sequelae. Some cases may occur by chance or have other causes. The role of pertussis vaccine as a prime or concomitant factor in the aetiology of these illnesses cannot be determined in any individual case. The balance of possible risk against known benefits from pertussis immunisation supports continued use of the vaccine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504540      PMCID: PMC1679309          DOI: 10.1136/bmj.307.6913.1171

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  17 in total

1.  Permanent brain damage and pertussis vaccination: is the end of the saga in sight?

Authors:  A H Griffith
Journal:  Vaccine       Date:  1989-06       Impact factor: 3.641

2.  Neurological complications of pertussis inoculation.

Authors:  M Kulenkampff; J S Schwartzman; J Wilson
Journal:  Arch Dis Child       Date:  1974-01       Impact factor: 3.791

3.  Estimation of relative risk from individually matched series.

Authors:  O S Miettinen
Journal:  Biometrics       Date:  1970-03       Impact factor: 2.571

4.  Infantile spasms and pertussis immunisation.

Authors:  M H Bellman; E M Ross; D L Miller
Journal:  Lancet       Date:  1983-05-07       Impact factor: 79.321

Review 5.  Whooping cough and whooping cough vaccine: the risks and benefits debate.

Authors:  D L Miller; R Alderslade; E M Ross
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

6.  The National Childhood Encephalopathy study: a 10-year follow-up. A report on the medical, social, behavioural and educational outcomes after serious, acute, neurological illness in early childhood.

Authors:  N Madge; J Diamond; D Miller; E Ross; C McManus; J Wadsworth; W Yule; B Frost
Journal:  Dev Med Child Neurol Suppl       Date:  1993-07

7.  A children's behaviour questionnaire for completion by teachers: preliminary findings.

Authors:  M Rutter
Journal:  J Child Psychol Psychiatry       Date:  1967-05       Impact factor: 8.982

8.  Pertussis immunisation and serious acute neurological illness in children.

Authors:  D L Miller; E M Ross; R Alderslade; M H Bellman; N S Rawson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

9.  A developmental test based on the STYCAR sequences used in the National Childhood Encephalopathy Study.

Authors:  M H Bellman; N S Rawson; J Wadsworth; E M Ross; S Cameron; D L Miller
Journal:  Child Care Health Dev       Date:  1985 Sep-Oct       Impact factor: 2.508

10.  Vaccination against whooping-cough. Efficacy versus risks.

Authors:  G T Stewart
Journal:  Lancet       Date:  1977-01-29       Impact factor: 79.321

View more
  13 in total

1.  MMR vaccination and autism 1998.

Authors:  A Nicoll; D Elliman; E Ross
Journal:  BMJ       Date:  1998-03-07

Review 2.  The complicated task of monitoring vaccine safety.

Authors:  S S Ellenberg; R T Chen
Journal:  Public Health Rep       Date:  1997 Jan-Feb       Impact factor: 2.792

Review 3.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

4.  Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.

Authors:  S Donnelly; C E Loscher; M A Lynch; K H Mills
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Monovalent pertussis vaccine no longer available.

Authors:  R Joyce
Journal:  BMJ       Date:  1994-01-29

Review 6.  Characteristics of materials distributed by drug companies. An evaluation of appropriateness.

Authors:  D Stryer; L A Bero
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

Review 7.  Safety of routine childhood vaccinations. An epidemiological review.

Authors:  R T Chen; G Mootrey; F DeStefano
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

Review 8.  Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children.

Authors:  Gladymar Perez Chacon; Jessica Ramsay; Christopher G Brennan-Jones; Marie J Estcourt; Peter Richmond; Patrick Holt; Tom Snelling
Journal:  Cochrane Database Syst Rev       Date:  2021-09-06

9.  The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia.

Authors:  Catherine King; Julie Leask
Journal:  BMC Public Health       Date:  2017-01-23       Impact factor: 3.295

10.  Did a then unknown virus, HHV-6/7, give rise to the whooping cough vaccine controversy of the 1970s?

Authors:  Philip P Mortimer
Journal:  Epidemiol Infect       Date:  2016-06-23       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.